What does accf aha stand for?
The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have jointly produced guidelines in the area of cardiovascular disease since 1980.
What is GDMT in heart failure?
GDMT = guideline directed medical therapy, defined as filling one or more prescription for carvedilol, metoprolol, or bisoprolol and an ACEI or ARB in the 90-day pre-implant period. COPD = chronic obstructive pulmonary disease. CHF = congestive heart failure.
What does HFpEF mean?
INTRODUCTION Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome in which patients have signs and symptoms of HF as the result of high left ventricular (LV) filling pressure despite normal or near normal LV ejection fraction (LVEF; ≥50 percent) [1-5].
What is a neprilysin inhibitor?
Neprilysin inhibitors are a new class of drugs used to treat high blood pressure and heart failure. They work by blocking the action of neprilysin thus preventing the breakdown of natriuretic peptides.
What is GDMT for HFpEF?
HFpEF is a prevalent clinical syndrome with increased cardiovascular morbidity and mortality. Specific guideline-directed medical therapy (GDMT) for HFpEF is not established due to lack of positive outcome data from randomized controlled trials (RCTs) and limitations of available studies.
What is the difference between diastolic heart failure and HFpEF?
The heart can’t pump with enough force to push enough blood into circulation. Heart failure with preserved ejection fraction (HFpEF), also called diastolic failure (or diastolic dysfunction): The left ventricle loses its ability to relax normally (because the muscle has become stiff).
Which is worse HFpEF or HFrEF?
Prognosis is poor in both groups but 42% worse in HFrEF patients than HFpEF. Prognostic factors associated with outcome differs between HFrEF and HFpEF.
Why is Entresto a washout period?
Entresto cannot be combined with an ACE inhibitor, and a 36-hour washout period is required between these 2 therapies to minimize the potential for life-threatening angioedema. This represents a huge opportunity for pharmacists to intervene and help prevent a potentially catastrophic medication error.